Management of the transitional urology patient: The role of the adult reconstructive urologist

KA Scarberry, RA Gor, RC Kovell - Current Urology Reports, 2021 - Springer
Abstract Purpose of Review Patients with congenital urologic conditions present unique
challenges as adults. Herein, we review the literature relevant to the adult reconstructive …

Review of current neurogenic bladder best practices and international guidelines

UK Mete, CR Powell - Current Bladder Dysfunction Reports, 2020 - Springer
Abstract Purpose of Review Current guidelines for neurogenic bladder (NGB) contain
contrasting recommendations in several areas. In this review, the current literature published …

[HTML][HTML] Frontiers in the clinical applications of botulinum toxin A as treatment for neurogenic lower urinary tract dysfunction

YH Jiang, SF Chen, HC Kuo - International Neurourology Journal, 2020 - ncbi.nlm.nih.gov
Patients with neurogenic lower urinary tract dysfunction (NLUTD) experience urinary
incontinence with or without difficult urination, which might promote recurrent urinary tract …

[PDF][PDF] Evaluation, treatment, and surveillance of neurogenic detrusor overactivity in spinal cord injury patients

A Alsulihem, J Corcos - Neuroimmunology and Neuroinflammation, 2019 - f.oaes.cc
Neurogenic detrusor overactivity is a common urodynamic finding in patients with supra-
sacral spinal cord injury. Early evaluation, stepped management, and close follow-up …

Clinical application of botulinum neurotoxin in lower-urinary-tract diseases and dysfunctions: Where are we now and what more can we do?

HC Kuo - Toxins, 2022 - mdpi.com
Botulinum toxin A (Botox) had been considered a promising drug that has an effect on
functional disorders of the lower urinary tract. Because Botox exhibits anti-inflammatory and …

[PDF][PDF] Neuro-urology

B Blok, D Castro-Diaz, G Del Popolo… - Arnhem: European …, 2015 - medi-guide.meditool.cn
1.1 Aim and objectives The European Association of Urology (EAU) Neuro-Urology
Guidelines aim to provide information for clinical practitioners on the incidence, definitions …

[HTML][HTML] Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury-Part 2 …

YL Kao, JT Chen, SL Chen, IH Shao, CC Wang… - Urological …, 2023 - journals.lww.com
Bladder management of chronic spinal cord injured (SCI) patients usually starts with
conservative treatment or minimally invasive procedures. This article reports the current …

The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review

B Toia, MH Pakzad, R Hamid, DN Wood… - Neurourology and …, 2020 - Wiley Online Library
Aims To investigate the role of onabotulinumtoxinA (BTX‐A) injections in patients with failed
augmentation cystoplasty for neuropathic or idiopathic detrusor overactivity (NDO or IDO) …

Botulinumtoxin Injection Versus Augmentation Cystoplasty for Neurogenic Bladder: Where Do We Stand?

T Sweeney, K Zilinskas, L Cox - Current Bladder Dysfunction Reports, 2023 - Springer
Abstract Purpose of Review Patients with neurogenic bladder often present with overactive,
low capacity, and poorly compliant bladders with discoordination of their internal and …

Toxina botulínica en el tratamiento de la hiperactividad vesical neurógena y no neurológica

M Baron, MAP Verbe - EMC-Urología, 2024 - Elsevier
La inyección de toxina botulínica en el detrusor es un tratamiento validado, de segunda
línea, de la incontinencia urinaria por hiperactividad vesical en los pacientes no …